Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

Joseph A. Sparano; Lawrence J. Brandt; Janice P. Dutcher; Jon S. DuBois; Michael B. Atkins

Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

Joseph A. Sparano
, Lawrence J. Brandt
, Janice P. Dutcher
, Jon S. DuBois
, Michael B. Atkins

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Abstract

Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.

Original language	English
Pages (from-to)	617-618
Number of pages	2
Journal	Annals of Internal Medicine
Volume	118
Issue number	8
State	Published - 15 Apr 1993
Externally published	Yes

Cite this

@article{1dbf549e010246e1bde9d61595df213a,

title = "Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2",

abstract = "Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.",

author = "Sparano, \{Joseph A.\} and Brandt, \{Lawrence J.\} and Dutcher, \{Janice P.\} and DuBois, \{Jon S.\} and Atkins, \{Michael B.\}",

year = "1993",

month = apr,

day = "15",

language = "English",

volume = "118",

pages = "617--618",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "8",

}

TY - JOUR

T1 - Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

AU - Sparano, Joseph A.

AU - Brandt, Lawrence J.

AU - Dutcher, Janice P.

AU - DuBois, Jon S.

AU - Atkins, Michael B.

PY - 1993/4/15

Y1 - 1993/4/15

N2 - Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.

AB - Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.

UR - https://www.scopus.com/pages/publications/0027419329

M3 - Article

C2 - 8452327

AN - SCOPUS:0027419329

SN - 0003-4819

VL - 118

SP - 617

EP - 618

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 8

ER -

Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

Abstract

Fingerprint

Cite this